Ivosidenib In Idh1-mutant, Chemotherapy-refractory Cholangiocarcinoma (Claridhy): A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 3 Study.
This is the report of a phase 3 study assessing efficacy and safety of ivosidenib, a small-molecule [...]Read more
Webinar: MANAGEMENT OF HCC DURING COVID-19: ILCA GUIDANCEDate: Friday, April 17, 2020 at 3:00 PM CEST / [...]Read more
COVID-Hep is a registry implemented at the University of Oxford, UK to collect data on patients with any [...]Read more
Hepatology, 2020 Jan 22 [Online ahead of print] In this study, the cooperation between MYC and beta-catenin [...]Read more